- CSR Summary Not Yet Available
- NCT01689532
- Primary Citation
- Data Specification Not Available
Trial Information
Generic NameSirukumabProduct NamePLIVENSIATherapeutic AreaMuscle, Bone, and Cartilage DiseasesEnrollment122% Female73.8%% WhiteN/A
Product ClassAntirheumatic Agents - Biologic Response ModifiersSponsor Protocol NumberCNTO136ARA3001Data PartnerJohnson & JohnsonCondition StudiedArthritis, RheumatoidMean/Median Age (Years)55.1
Supporting Documentation
- Collected Datasets Available
- Data Definition Specification Available
- Protocol with Amendments Available
- Statistical Analysis Plan Available
- Clinical Study Report Available